The Smart Car (Avastin) vs. the Lexus (Eylea). They both get you there but one costs a lot more.

A recent study showed Avastin ($60 per dose, used off-label) was just as effective as Eylea ($1850 per dose, FDA approved treatment) in terms of visual acuity for the treatment of CRVO.
The Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2) evaluated the safety and efficacy of the two drugs. In the study, patients received either an Avastin or Eylea injection every 4 weeks for 6 months.  At the six month follow up, visual acuity improved from 20/100 to 20/40 for both groups and the rates of adverse events, such as elevated intraocular pressure, were low and similar in both groups. (via)

Get in Touch


Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.

Related Articles

Latest Posts